Polyclonal adaptive immune system

The polyclonal adaptive immune system is a complex physiological network composed of diverse populations of T and B lymphocytes that provide highly specific and long-lasting protection against pathogens. It is characterized by its ability to recognize a vast array of antigens through a diverse repertoire of receptors generated by V(D)J recombination, allowing for a tailored response to specific threats (Janeway et al., 2001). While not a single molecular target, the system is the focus of numerous therapeutic interventions; for instance, vaccines stimulate polyclonal expansion for prophylaxis, while immunosuppressants dampen its activity to treat autoimmune disorders (NIH, 2023). In oncology, checkpoint inhibitors leverage the adaptive immune system to identify and eliminate malignant cells by removing inhibitory signals on T cells (Pardoll, 2012). Because it represents a collective of various cell types and molecular pathways rather than a discrete protein or receptor, it is classified as a biological system rather than a specific therapeutic target.

Other names

Adaptive immune systemAcquired immune systemLymphocyte-mediated immunitySpecific immune system

Broad modulation of lymphocyte activation, clonal expansion, and effector functions across a diverse repertoire of T and B cell clones.